NCT06013618 2025-06-17
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Sun Yat-sen University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT05638451 2024-06-05
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Zhujiang Hospital
Phase 2 Unknown
NCT06431685 2024-05-28
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
Sichuan University
Phase 1 Recruiting
NCT06220552 2024-01-24
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Recruiting
NCT04728568 2021-08-10
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma
Beijing Tiantan Hospital
Phase NA Unknown